Browsing by Author Guillemin, Giles

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 7 of 7
Issue DateTitleAuthor(s)Citation
2014Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeletonBooth, David; Brilot-Turville, Fabienne; Dale, Russell; Kumaran, Raani-Yogeeta; Mathey, Emily; Merheb, V.; Pathmanandavel, Karrnan; Ramanathan, Sudarshini; Sinmaz, Nese; Tantsis, Esther; Wienholt, Louise; Clark, Damien; Guillemin, Giles; Lim, Chai K; Prelog, Kristina; Western Clinical School: Westmead Millennium Institute; Childrens Hospital Westmead: Paediatrics & Child Health; Childrens Hospital Westmead: Paediatrics & Child Health; Children's Hospital Westmead: Childrens Medical Research Ins; Central Clinical School: Medicine; Childrens Hospital Westmead: Paediatrics & Child Health; Physics; Western Clinical School: Medicine (Westmead); Children's Hospital Westmead: Childrens Medical Research Ins; Children's Hospital Westmead: Childrens Medical Research Ins; Central Clinical School: MedicineAntibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton, Neurology: Neuroimmunology and Neuroinflammation, vol.2014, 1, 2014,pp 1-10
2015Differential expression of sirtuins in the aging rat brainChan-Ling, Tailoi; Mansour, Hussein; Braidy, Nady; Grant, Ross S.; Guillemin, Giles; Jayasena, Tharusha; Poljak, Anne; Sachdev, Perminder S.; Smythe, George A.; School of Medical Sciences: Anatomy & Histology; School of Medical Sciences: PathologyDifferential expression of sirtuins in the aging rat brain, Frontiers in Cellular Neuroscience, vol.9, MAY, 2015,pp 1-16
2015An effective, low-cost method for achieving and maintaining hypoxia during cell culture studiesBakmiwewa, Supun; Ball, Helen; Hunt, Nicholas; Guillemin, Giles; Heng, Benjamin; Medicine; School of Medical Sciences: Pathology; School of Medical Sciences: PathologyAn effective, low-cost method for achieving and maintaining hypoxia during cell culture studies, BioTechniques, vol.59, 4, 2015,pp 223-229
2017Human regulatory macrophages are potent in suppression of the xenoimmune response via indoleamine-2,3-dioxygenase-involved mechanism(s)Guo, Fei; Hawthorne, Wayne; Hu, Min; Huang, Dandan; Yi, Shounan; Zhao, Yuanfei; Guillemin, Giles; Heng, Benjamin; Lim, Chai K; Westmead Clinical School: Westmead Institute for Medical Res; Westmead Clinical School: Surgery; Westmead Clinical School: Westmead Institute for Medical Res; Westmead Clinical School: Westmead Institute for Medical Res; Westmead Clinical School: Westmead Institute for Medical Res; Westmead Clinical School: Westmead Institute for Medical ResHuman regulatory macrophages are potent in suppression of the xenoimmune response via indoleamine-2,3-dioxygenase-involved mechanism(s), Xenotransplantation, vol.24, 5, 2017,pp 1-11
2014Involvement of the Kynurenine Pathway in Human Glioma PathophysiologyZinger, Anna; Adams, Seray; Braidy, Nady; Brew, Bruce J.; Bustamante, Sonia; Guillemin, Giles; Lim, Chai K; McDonald, Kerrie; Sundaram, Gayathri; Teo, Charlie; School of Medical Sciences: PathologyInvolvement of the Kynurenine Pathway in Human Glioma Pathophysiology, PloS One, vol.9, 11, 2014,pp 1-28
2015Lycopene pretreatment ameliorates acute ethanol induced NAD+ depletion in human astroglial cellsGrant, Ross; Guest, Jade; Guillemin, Giles; Heng, Benjamin; Medicine Faculty OfficeLycopene pretreatment ameliorates acute ethanol induced NAD+ depletion in human astroglial cells, Oxidative Medicine and Cellular Longevity, vol.2015, N/A, 2015,pp 1-8
2015The p38-MK2-HuR pathway potentiates EGFRvIII-IL-1β-driven IL-6 secretion in glioblastoma cellsAmmit, Alaina; Buckland, Michael; Grewal, Thomas; Gurgis, Fadi; Munoz, Lenka; Tang, M X M; Yeung, Yiu To Otto; Guillemin, Giles; Haapasalo, H; Haapasalo, J; Heng, Benjamin; Pharmacy; School of Medical Sciences: Brain and Mind Centre; Pharmacy; School of Medical Sciences: Pharmacology; School of Medical Sciences: Pathology; Pharmacy; School of Medical Sciences: PharmacologyThe p38-MK2-HuR pathway potentiates EGFRvIII-IL-1β-driven IL-6 secretion in glioblastoma cells, Oncogene, vol.34, 22, 2015,pp 2934-2942